DRUG

#2302
Bright Minds Biosciences Inc. - common stock
88.0 7 USD
-1.82%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
88.07
88.07
Range Annuel
23.18
123.75
Changement quotidien
-1.82%
Changement Mensuel
-1.01%
Evolution sur 6 mois
+26.27%
Changement Annuel
+224.98%
Clôture Précédente
89.7 0
Open
88.0 7
Low
88.0 7
High
88.0 7
Volume
24
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 20212022202320242025

Bright Minds Biosciences Inc. - common stock

Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use. It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens. The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York.

Nouvelles